Navigation Links
PreHistin ® Allergy Defense Formula Wins 2011 Best New Product Award at ECRM Allergy Show
Date:3/10/2011

IRVINE, Calif., March 10, 2011 /PRNewswire/ -- Cobalis Corp.'s (Pink Sheets: CLSC) http://www.prehistin.com/  [PreHistin® Allergy Defense Formula], the first ever pre-histamine, has taken the coveted 2011 Best New Product Award at the ECRM Cough, Cold and Allergy show held in Orlando, FL, February 28-March 3. PreHistin® regulates overproduction of the key allergen antibody IgE to restore a normal response to both seasonal and year-round allergens, which according to leading US allergist and clinical researcher Dr. Paul H. Ratner, MD is "no allergic response at all!"

"We are very proud that PreHistin® was selected by the country's leading retail and pharmacy buyers as 'Best New Product of the Year' out of a field of thousands of products. In introducing PreHistin® as the world's first PRE-histamine, we have literally created an entirely new category in allergy care, as well as offering the more than 60 million Americans who suffer from seasonal and year-round allergies the first major new option available in years – the opportunity to regulate allergen antibody IgE levels to restore a normal, non-reactive response to allergens, as opposed to treating symptoms after an allergic reaction has started. We thank the retailers and distributors who attended this show for awarding us this great honor and recognition," said Marty Marion, CEO of Cobalis Corp.

PreHistin® is now on shelves at one of the nation's two largest drugstore chains, and is expected to be on pharmacy and grocery shelves across the country very quickly. Indoor and outdoor allergy sufferers, who need relief seasonally or year-round, can feel the benefits of PreHistin® in as little as a few weeks of regular use. The all-natural formula of PreHistin® is a lozenge dissolved under the tongue and then swallowed twice a day during allergy season, or year-round for those who suffer from indoor allergens like dust, mold and pet dander.

"I recommend that all of my patients who suffer from allergies use PreHistin®," said allergist Dr. Paul Ratner. "Not only is the product safe but it is extremely effective, completely non-drowsy, and has no side effects."

Readers who are interested in more information should visit www.prehistin.com. To arrange a media interview with Dr. Paul Ratner please contact Nancy Trent or Pam Wadler at 212-966-0024 or send an email to pam@trentandcompany.com.

ABOUT PREHISTIN® ALLERGY DEFENSE FORMULA

PreHistin® Allergy Defense Formula is a unique, patented cobalamin complex product that helps rebalance the immune system to lower allergen antibody IgE levels, and regulate the release of symptom-linked histamine which is linked to the onset of symptoms such as sneezing, itchy watery eyes, runny nose and nasal congestion. PreHistin® is a cherry-flavored lozenge that is dissolved under the tongue and then swallowed twice a day, usually starting before the allergy season, or taken daily for those suffering from year-round allergies. PreHistin® has no known side effects, is 100% non-drowsy, and has no contraindications with any other medications. In clinical trials on thousands of allergy sufferers, PreHistin® was shown to be safe and effective in reducing nasal symptoms.

ABOUT COBALIS CORP.—PREHISTIN®

Cobalis Corp. is a specialty pharmaceutical, nutraceutical and preventive healthcare product development and marketing company. Its flagship product, PreHistin® Allergy Defense Formula, "The World's First Pre-Histamine", is designed to mitigate overproduction of IgE levels and restore a normal response to seasonal and year-round indoor and outdoor allergens. PreHistin® is now available without prescription for both long-term and daily use.

For PreHistin® product information please visit www.PreHistin.com or call toll free

1-877-4POLLEN (1-877-476-5536). For additional company information please visit the corporate website at www.Cobalis.com. CONTACTCobalis Corp.949-260-0123Chas Radovich, PresidentMartin Marion, CEOinfo@cobalis.com
'/>"/>

SOURCE Cobalis Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Cobalis Corp. Receives $415,000 First Purchase Order from Major Retail Pharmacy for PreHistin® Allergy Defense Formula
2. Sams Club® Offers Free Allergy Health Screenings
3. Good Clostridia in the Gut Protect from Allergy and Autoimmunity
4. Cinryze® (C1 Esterase Inhibitor [Human]) Data Presented at 2010 International Scientific Conference of the World Allergy Organization (WAO)
5. Pharmaxis Previews New Bronchial Challenge Test at the Annual Meeting of the American College of Allergy, Asthma and Immunology
6. Cetero Research Leads Industry in Human Allergy Models
7. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
8. National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production
9. Asthmatx Presents Impact of Bronchial Thermoplasty on Allergy Practices at ACAAI Annual Meeting
10. ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI)
11. Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary Endpoint in a Study of Adult Subjects With a History of Grass Pollen Allergies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... , Feb. 11, 2016 Brain Cancer ... treatment method at West Cancer Center . ... fields to inhibit cancer cell replication causing death of ... than a decade to show a significant extension in ... (GBM) patients. Currently, West Cancer Center is the only ...
(Date:2/11/2016)... , Feb. 11, 2016  AbbVie, a ... AbbVie Rheumatology Scholarship, designed to provide financial support ... as they pursue higher education goals. Fifteen scholars ... the 2016-2017 school year. The AbbVie Rheumatology Scholarship ... Haas , vice president, corporate social responsibility, brand ...
(Date:2/11/2016)... 11, 2016 PLAD, Inc. (OTC Pink: PLAD) is ... sales exceeding company targets, are adding key personnel to ... from the United States Patent and Trademark Office for ... Executive Officer of PLAD, Inc.  In January, PLAD established ... with two new customers, Cumberland Goodwill EMS ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... Student-doctors from Western ... (AOA) Match Program Tuesday, February 9, taking one of the final steps in ... medical education positions across the country. Of the 103 student-doctors who comprise the ...
(Date:2/11/2016)... ... 12, 2016 , ... The Journal of Pain Research has seen ... SJR uses data taken from the Scopus database (Elsevier B.V.) and is a measure ... by the journal over a three year period and also the importance of the ...
(Date:2/11/2016)... ... ... Hall Integrative Health and Chiropractic, PC which focuses on ... in March. All seven practices are set to start accepting patients in March ... According to this 2011 CNN article it is possible: http://www.cnn.com/2011/HEALTH/01/28/reverse.diabetes/ . Current ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... upcoming Feb. 23 webinar, “Intel’s Direct-to-Employee Benefit Model: A Case Study for Plans ... Catholic health care system that’s partnering with Intel on value-based health benefits program ...
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
Breaking Medicine News(10 mins):